CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS
4.1 Overview
4.1.1 Market size and forecast
4.2 Media and Reagents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Media and Reagents Cell Line and Membrane Market by Type
4.2.4.1 Serum Market size and forecast, by region
4.2.4.2 Media Market size and forecast, by region
4.2.4.3 Reagents Market size and forecast, by region
4.3 Equipments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Equipments Cell Line and Membrane Market by Type
4.3.4.1 Biosafety Cabinets Market size and forecast, by region
4.3.4.2 Cell Counters and Viability Systems Market size and forecast, by region
4.3.4.3 Incubators Market size and forecast, by region
4.3.4.4 Centrifuges Market size and forecast, by region
4.3.4.5 Bioreactors Market size and forecast, by region
4.3.4.6 Storage Equipment Market size and forecast, by region
4.3.4.7 Others Market size and forecast, by region
4.4 Accessories and Consumables
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Non Mammalian Cell Line
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Non Mammalian Cell Line Cell Line and Membrane Market by Type
5.2.4.1 Insects Market size and forecast, by region
5.2.4.2 Amphibians Market size and forecast, by region
5.3 Mammalian Cell Line
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE
6.1 Overview
6.1.1 Market size and forecast
6.2 Recombinant cell lines
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Primary cell lines
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Hybridomas
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Continuous cell lines
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Academic and Research Institutes
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Products
8.2.2.1 North America Media and Reagents Cell Line and Membrane Market by Type
8.2.2.2 North America Equipments Cell Line and Membrane Market by Type
8.2.3 North America Market size and forecast, by Source
8.2.3.1 North America Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.2.4 North America Market size and forecast, by Type
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Products
8.2.6.1.2 Market size and forecast, by Source
8.2.6.1.3 Market size and forecast, by Type
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Products
8.2.6.2.2 Market size and forecast, by Source
8.2.6.2.3 Market size and forecast, by Type
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Products
8.2.6.3.2 Market size and forecast, by Source
8.2.6.3.3 Market size and forecast, by Type
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Products
8.3.2.1 Europe Media and Reagents Cell Line and Membrane Market by Type
8.3.2.2 Europe Equipments Cell Line and Membrane Market by Type
8.3.3 Europe Market size and forecast, by Source
8.3.3.1 Europe Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.3.4 Europe Market size and forecast, by Type
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Products
8.3.6.1.2 Market size and forecast, by Source
8.3.6.1.3 Market size and forecast, by Type
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Products
8.3.6.2.2 Market size and forecast, by Source
8.3.6.2.3 Market size and forecast, by Type
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Products
8.3.6.3.2 Market size and forecast, by Source
8.3.6.3.3 Market size and forecast, by Type
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Products
8.3.6.4.2 Market size and forecast, by Source
8.3.6.4.3 Market size and forecast, by Type
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Products
8.3.6.5.2 Market size and forecast, by Source
8.3.6.5.3 Market size and forecast, by Type
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Products
8.3.6.6.2 Market size and forecast, by Source
8.3.6.6.3 Market size and forecast, by Type
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Products
8.4.2.1 Asia-Pacific Media and Reagents Cell Line and Membrane Market by Type
8.4.2.2 Asia-Pacific Equipments Cell Line and Membrane Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Source
8.4.3.1 Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.4.4 Asia-Pacific Market size and forecast, by Type
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Products
8.4.6.1.2 Market size and forecast, by Source
8.4.6.1.3 Market size and forecast, by Type
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Products
8.4.6.2.2 Market size and forecast, by Source
8.4.6.2.3 Market size and forecast, by Type
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Products
8.4.6.3.2 Market size and forecast, by Source
8.4.6.3.3 Market size and forecast, by Type
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Products
8.4.6.4.2 Market size and forecast, by Source
8.4.6.4.3 Market size and forecast, by Type
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Products
8.4.6.5.2 Market size and forecast, by Source
8.4.6.5.3 Market size and forecast, by Type
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Products
8.4.6.6.2 Market size and forecast, by Source
8.4.6.6.3 Market size and forecast, by Type
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Products
8.5.2.1 LAMEA Media and Reagents Cell Line and Membrane Market by Type
8.5.2.2 LAMEA Equipments Cell Line and Membrane Market by Type
8.5.3 LAMEA Market size and forecast, by Source
8.5.3.1 LAMEA Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.5.4 LAMEA Market size and forecast, by Type
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Products
8.5.6.1.2 Market size and forecast, by Source
8.5.6.1.3 Market size and forecast, by Type
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Products
8.5.6.2.2 Market size and forecast, by Source
8.5.6.2.3 Market size and forecast, by Type
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Products
8.5.6.3.2 Market size and forecast, by Source
8.5.6.3.3 Market size and forecast, by Type
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Products
8.5.6.4.2 Market size and forecast, by Source
8.5.6.4.3 Market size and forecast, by Type
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Advanced Instruments LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 AGC Biologics
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cytiva Lifesciences
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Sartorius
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Cellgenix Gmbh
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Premas Biotech
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Selexis SA
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Samsung Biologics
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Lonza
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermofisher Scientific Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 PromoCell
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 ProBioGen
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
TABLE 1. GLOBAL CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 2. CELL LINE AND MEMBRANE MARKET, FOR MEDIA AND REAGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. CELL LINE AND MEMBRANE MARKET FOR MEDIA AND REAGENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. CELL LINE AND MEMBRANE MARKET, FOR SERUM, BY REGION, 2021-2031 ($MILLION)
TABLE 6. CELL LINE AND MEMBRANE MARKET, FOR MEDIA, BY REGION, 2021-2031 ($MILLION)
TABLE 7. CELL LINE AND MEMBRANE MARKET, FOR REAGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 8. CELL LINE AND MEMBRANE MARKET, FOR EQUIPMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 9. CELL LINE AND MEMBRANE MARKET FOR EQUIPMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. GLOBAL EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 11. CELL LINE AND MEMBRANE MARKET, FOR BIOSAFETY CABINETS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. CELL LINE AND MEMBRANE MARKET, FOR CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. CELL LINE AND MEMBRANE MARKET, FOR INCUBATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. CELL LINE AND MEMBRANE MARKET, FOR CENTRIFUGES, BY REGION, 2021-2031 ($MILLION)
TABLE 15. CELL LINE AND MEMBRANE MARKET, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. CELL LINE AND MEMBRANE MARKET, FOR STORAGE EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 17. CELL LINE AND MEMBRANE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. CELL LINE AND MEMBRANE MARKET, FOR ACCESSORIES AND CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 19. CELL LINE AND MEMBRANE MARKET FOR ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. GLOBAL CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 21. CELL LINE AND MEMBRANE MARKET, FOR NON MAMMALIAN CELL LINE, BY REGION, 2021-2031 ($MILLION)
TABLE 22. CELL LINE AND MEMBRANE MARKET FOR NON MAMMALIAN CELL LINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. GLOBAL NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 24. CELL LINE AND MEMBRANE MARKET, FOR INSECTS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. CELL LINE AND MEMBRANE MARKET, FOR AMPHIBIANS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. CELL LINE AND MEMBRANE MARKET, FOR MAMMALIAN CELL LINE, BY REGION, 2021-2031 ($MILLION)
TABLE 27. CELL LINE AND MEMBRANE MARKET FOR MAMMALIAN CELL LINE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. GLOBAL CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. CELL LINE AND MEMBRANE MARKET, FOR RECOMBINANT CELL LINES, BY REGION, 2021-2031 ($MILLION)
TABLE 30. CELL LINE AND MEMBRANE MARKET FOR RECOMBINANT CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. CELL LINE AND MEMBRANE MARKET, FOR PRIMARY CELL LINES, BY REGION, 2021-2031 ($MILLION)
TABLE 32. CELL LINE AND MEMBRANE MARKET FOR PRIMARY CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. CELL LINE AND MEMBRANE MARKET, FOR HYBRIDOMAS, BY REGION, 2021-2031 ($MILLION)
TABLE 34. CELL LINE AND MEMBRANE MARKET FOR HYBRIDOMAS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. CELL LINE AND MEMBRANE MARKET, FOR CONTINUOUS CELL LINES, BY REGION, 2021-2031 ($MILLION)
TABLE 36. CELL LINE AND MEMBRANE MARKET FOR CONTINUOUS CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. GLOBAL CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. CELL LINE AND MEMBRANE MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 ($MILLION)
TABLE 39. CELL LINE AND MEMBRANE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. CELL LINE AND MEMBRANE MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 41. CELL LINE AND MEMBRANE MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. CELL LINE AND MEMBRANE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 43. CELL LINE AND MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 44. CELL LINE AND MEMBRANE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 45. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 47. NORTH AMERICA EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 50. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. U.S. CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 54. U.S. CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 55. U.S. CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 56. U.S. CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CANADA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 58. CANADA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 59. CANADA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 60. CANADA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. MEXICO CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 62. MEXICO CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 63. MEXICO CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. MEXICO CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. EUROPE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 66. EUROPE MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. EUROPE EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 68. EUROPE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 69. EUROPE NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. EUROPE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 71. EUROPE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. EUROPE CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 73. GERMANY CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 74. GERMANY CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 75. GERMANY CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 76. GERMANY CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. FRANCE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 78. FRANCE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 79. FRANCE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 80. FRANCE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. UK CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 82. UK CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 83. UK CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. UK CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. ITALY CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 86. ITALY CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 87. ITALY CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 88. ITALY CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. SPAIN CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 90. SPAIN CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 91. SPAIN CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. SPAIN CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 94. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 95. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 96. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 98. ASIA-PACIFIC MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. ASIA-PACIFIC EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 100. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 101. ASIA-PACIFIC NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 102. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 103. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 104. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 105. JAPAN CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 106. JAPAN CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 107. JAPAN CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 108. JAPAN CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. CHINA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 110. CHINA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 111. CHINA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 112. CHINA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 113. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 114. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 115. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 116. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 117. INDIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 118. INDIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 119. INDIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 120. INDIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 121. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 122. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 123. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 124. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 125. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 126. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 127. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 128. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 129. LAMEA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 130. LAMEA MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 131. LAMEA EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 132. LAMEA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 133. LAMEA NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 134. LAMEA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 135. LAMEA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 136. LAMEA CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 137. BRAZIL CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 138. BRAZIL CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 139. BRAZIL CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 140. BRAZIL CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 141. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 142. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 143. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 144. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 145. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 146. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 147. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 148. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 149. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
TABLE 150. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
TABLE 151. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 152. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 153.ADVANCED INSTRUMENTS LLC: COMPANY SNAPSHOT
TABLE 154.ADVANCED INSTRUMENTS LLC: OPERATING SEGMENTS
TABLE 155.ADVANCED INSTRUMENTS LLC: PRODUCT PORTFOLIO
TABLE 156.ADVANCED INSTRUMENTS LLC: NET SALES,
TABLE 157.ADVANCED INSTRUMENTS LLC: KEY STRATERGIES
TABLE 158.AGC BIOLOGICS: COMPANY SNAPSHOT
TABLE 159.AGC BIOLOGICS: OPERATING SEGMENTS
TABLE 160.AGC BIOLOGICS: PRODUCT PORTFOLIO
TABLE 161.AGC BIOLOGICS: NET SALES,
TABLE 162.AGC BIOLOGICS: KEY STRATERGIES
TABLE 163.CYTIVA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 164.CYTIVA LIFESCIENCES: OPERATING SEGMENTS
TABLE 165.CYTIVA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 166.CYTIVA LIFESCIENCES: NET SALES,
TABLE 167.CYTIVA LIFESCIENCES: KEY STRATERGIES
TABLE 168.SARTORIUS: COMPANY SNAPSHOT
TABLE 169.SARTORIUS: OPERATING SEGMENTS
TABLE 170.SARTORIUS: PRODUCT PORTFOLIO
TABLE 171.SARTORIUS: NET SALES,
TABLE 172.SARTORIUS: KEY STRATERGIES
TABLE 173.CELLGENIX GMBH: COMPANY SNAPSHOT
TABLE 174.CELLGENIX GMBH: OPERATING SEGMENTS
TABLE 175.CELLGENIX GMBH: PRODUCT PORTFOLIO
TABLE 176.CELLGENIX GMBH: NET SALES,
TABLE 177.CELLGENIX GMBH: KEY STRATERGIES
TABLE 178.PREMAS BIOTECH: COMPANY SNAPSHOT
TABLE 179.PREMAS BIOTECH: OPERATING SEGMENTS
TABLE 180.PREMAS BIOTECH: PRODUCT PORTFOLIO
TABLE 181.PREMAS BIOTECH: NET SALES,
TABLE 182.PREMAS BIOTECH: KEY STRATERGIES
TABLE 183.SELEXIS SA: COMPANY SNAPSHOT
TABLE 184.SELEXIS SA: OPERATING SEGMENTS
TABLE 185.SELEXIS SA: PRODUCT PORTFOLIO
TABLE 186.SELEXIS SA: NET SALES,
TABLE 187.SELEXIS SA: KEY STRATERGIES
TABLE 188.SAMSUNG BIOLOGICS: COMPANY SNAPSHOT
TABLE 189.SAMSUNG BIOLOGICS: OPERATING SEGMENTS
TABLE 190.SAMSUNG BIOLOGICS: PRODUCT PORTFOLIO
TABLE 191.SAMSUNG BIOLOGICS: NET SALES,
TABLE 192.SAMSUNG BIOLOGICS: KEY STRATERGIES
TABLE 193.LONZA: COMPANY SNAPSHOT
TABLE 194.LONZA: OPERATING SEGMENTS
TABLE 195.LONZA: PRODUCT PORTFOLIO
TABLE 196.LONZA: NET SALES,
TABLE 197.LONZA: KEY STRATERGIES
TABLE 198.THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT
TABLE 199.THERMOFISHER SCIENTIFIC INC: OPERATING SEGMENTS
TABLE 200.THERMOFISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
TABLE 201.THERMOFISHER SCIENTIFIC INC: NET SALES,
TABLE 202.THERMOFISHER SCIENTIFIC INC: KEY STRATERGIES
TABLE 203.PROMOCELL: COMPANY SNAPSHOT
TABLE 204.PROMOCELL: OPERATING SEGMENTS
TABLE 205.PROMOCELL: PRODUCT PORTFOLIO
TABLE 206.PROMOCELL: NET SALES,
TABLE 207.PROMOCELL: KEY STRATERGIES
TABLE 208.PROBIOGEN: COMPANY SNAPSHOT
TABLE 209.PROBIOGEN: OPERATING SEGMENTS
TABLE 210.PROBIOGEN: PRODUCT PORTFOLIO
TABLE 211.PROBIOGEN: NET SALES,
TABLE 212.PROBIOGEN: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
